This email address is being protected from spambots. You need JavaScript enabled to view it.
Facebook
Twitter
SP_SOCIAL_INSTAGRAM
YouTube
Linkedin
Home
About Us
About Us
Who We Are
Our History
Global Footprint
Careers
Our Partners
Contact Us
Governance
Board of Directors
Group Executive Management
South Africa Executive Management
Group Technical Leads
What We Do
What We Do
Clinical Research
Implementation Research
Health Programmes
POP INN
Aurum Global
Global Projects
Aurum Institute Ghana
Fundação Aurum
Expertise
Tuberculosis
HIV
Health Systems
Key Populations
COVID-19
Antimicrobial resistance (AMR)
Affiliates
CHAPS
IMPAACT4TB
INNOVA
Youth Health Africa
ASHA
GHI
Library
Resources
Publications
Annual Reports
Annual Financials
News & Updates
News
Latest News
Press Releases
Aurum in the News
Multimedia
Image Gallery
Multimedia
Watch: IMPAACT4TB Project 3HP rollout
We have carried Tuberculosis (TB) for far too long, we need to move away from a narrow focus on treatment in order to end TB. Despite TB being both a curable and treatable disease, millions of people...
PhD Opportunity
The International Division and Implementation Research Division at the Aurum Institute, the TB Centre and Johns Hopkins University, CHAI, Zimbabwe and KNCV Ethiopia are offering a PhD bursary to suppo...
High risk of Tuberculosis in people living with HIV
The Lancet Global Health journal reports the findings of a study of a host blood test that can find those at high risk of tuberculosis in people living with HIV. The blood mRNA biomarker differentiate...
New study: Optimising the delivery for tuberculosis preventive treatment
The Aurum Institute is implementing a new study to assess the delivery of TB preventive treatment (TPT) in three countries, to generate critical knowledge to improve TPT uptake, implementation and ou...
After setbacks, rollout of new TB prevention pills to start in six districts
This article was originally written by Tiyese Jeranji for Spotlight on 14th April 2021. After various delays and setbacks, new, less toxic, short-course tuberculosis (TB) prevention therapy is fi...
Aurum launches TB Preventative Treatment rollout in Ghana
Aurum Institute Ghana, recently launched the rollout of 3HP, a new, less toxic, short-course tuberculosis (TB) prevention therapy (TPT). This is part of the IMPAACT4TB project, implemented by a cons...
New grant to provide an analysis of programmatic treatment of drug-resistant TB
Aurum Senior Researcher Dr Yuri van der Heijden, has received a 5-year grant for a study on drug-resistant TB from the National Institutes of Health (NIH). Van der Heijden, holds a joint appointmen...
Fundação Aurum partners with Mozambican government to help end TB
Mozambique has shown its commitment to ending TB, with Prime Minister Carlos Agostinho do Rosário, attending the launch of the rollout of a new TB prevention therapy (TPT) recently. The Aurum Instit...
Aurum at 11th IAS Conference on HIV science
Aurum experts recently presented at the 11th International Aids Society (IAS) Conference, which brought together thousands of HIV professionals virtually from 18 to 21 July. On the opening day of the...
Improving availability of patient-friendly tuberculosis preventive therapy
Global partners working to tackle the tuberculosis (TB) epidemic have announced the latest in a package of measures to increase supply security and availability of a short-course TB preventive therapy...
Shorter weekly course of rifapentine-isoniazid associated with much higher treatment completion rates compared to longer daily course
A randomized trial found that treatment completion was higher among HIV-positive persons who were assigned a shorter course of rifapentine-isoniazid therapy to prevent tuberculosis disease compared to...
TB Prevention in People With HIV: How Short Can We Go?
...
Call to action for an invigorated drive to scale up TB prevention
...
Strengthening the Mentorship and Leadership Capacity of HIV/AIDS and Tuberculosis Researchers in South Africa
Desai, M.M., Göç, N., Chirwa, T., Manderson, L., Charalambous, S., Curry, L.A. and Linnander, E., 2021. Strengthening the Mentorship and Leadership Capacity of HIV/AIDS and Tuberculosis Researchers ...
Dablapmeds: A convenient shortcut to medication collection
The Aurum Institute continues to bring patient-centred healthcare solutions, this time, supporting the Department of Health Dablapmeds initiative. Dablap is a colloquial term for shortcut and is the n...
The Aurum Institute at the 52nd Union World Conference on Lung Health
Aurum has extensive experience in TB research, specifically TB treatment clinical trials, TB prevention trials with vaccines, preventive therapy, epidemiological studies, implementation research an...
Opt4TPT South Africa study team recruits and enrols participants
On 16 September 2021, the Opt4TPT study team in South Africa implemented by The Aurum Institute, started enrolling patients visiting the Chiawelo Community Health Centre (CHC) for antiretroviral the...
IMPAACT4TB Project statement responding to the WHO Global TB Report 2021
IMPAACT4TB Welcomes Gains in TB Prevention Among People Living With HIV, But Calls for Urgent Action to Address TB Prevention Deficits Among Children and Household Contacts of People Affected by TB ...
Concern as TB Preventative Treatment Declines
...
Ascent South Africa launches in Cape Town
The Adherence Support Coalition to End TB (ASCENT) project is collaborating with City Health, and TB HIV Care funded by the Global Fund to implement Digital Adherence Technologies (DATs), to sup...
Enter Part of Title
Display #
5
10
15
20
25
30
50
100
All
Page 3 of 8
Start
1
2
3
4
5
6
7
8
End
Popular Tags
AurumNews
228
Tuberculosis
157
Public Health
117
International
113
HIV
88
Clinical Research
77
Implementation Research
71
Impaact4tb
62
COVID-19
60
Aurum Ghana
53
Unitaid
42
Aurum Mozambique
29
Most Read
Aurum staff appointed to Vanderbilt University
Aurum delivers life-saving medication to homes
World Pharmacy Month: Aurum celebrates its pharmacists
Celebrating all women at POP INN
Recent Posts
Revolutionising Pediatric TB Prevention: Insights from the Rifapentine Dispersible Formulation Webinar
Prof Kaleebu receives the honorary title of Officer of the Most Excellent Order of the British Empire
World TB Day: Fundação Aurum participates in Costa do Sol Health Fair to end TB in Maputo
World TB Day 2024: Aurum Institute Ghana commits to ending TB in Ghana
Home
About Us
About Us
Who We Are
Our History
Global Footprint
Careers
Our Partners
Contact Us
Governance
Board of Directors
Group Executive Management
South Africa Executive Management
Group Technical Leads
What We Do
What We Do
Clinical Research
Implementation Research
Health Programmes
POP INN
Aurum Global
Global Projects
Aurum Institute Ghana
Fundação Aurum
Expertise
Tuberculosis
HIV
Health Systems
Key Populations
COVID-19
Antimicrobial resistance (AMR)
Affiliates
CHAPS
IMPAACT4TB
INNOVA
Youth Health Africa
ASHA
GHI
Library
Resources
Publications
Annual Reports
Annual Financials
News & Updates
News
Latest News
Press Releases
Aurum in the News
Multimedia
Image Gallery
Multimedia